It has been proposed that in patients with T1DM and T2DM, particularly those with concomitant diabetic nephropathy and diabetic retinopathy, oxidative stress increases locally produced MCP-1, which triggers macrophage-induced inflammation [13,14,15]. This evidence concerns the gene CCL2 and diabetic kidney disease.